PALLIATIVE TREATMENT OF ADVANCED CERVICAL CANCER WITH RADIOTHERAPY AND THAI HERBAL MEDICINE AS SUPPORTIVE REMEDY

Authors

  • Montien PESEE Department of Radiology, Srinagarind Hospital, Faculty of Medicine, Khon Kaen University
  • Wichit KIRDPON Division of Nuclear Medicine, Department of Radiology, Srinagarind Hospital, Faculty of Medicine, Khon Kaen University
  • Sukachart KIRDPON Department of Pediatrics, Faculty of Medicine, Khon Kaen University
  • Anucha PUAPAIROJ Department of Pathology, Srinagarind Hospital, Faculty of Medicine, Khon Kaen University
  • Pongsiri PRATHNADI Department of Surgery, Faculty of Medicine, Chiang Mai University

Keywords:

Advanced cervical carcinoma, palliative radiotherapy, Thai herbal medicine

Abstract

OBJECTIVE: To evaluate the supportive effect of Thai herbal medicine, Vilac Plus (G716/ 45) on standard radiotherapy in comparison with historic control from the literature reports the results of treatment in stage IIIB-IV cervical cancer.

PATIENTS AND METHODS: During the period of March 2003 to June 2005. Thirty patients in advanced cervical cancer stage IIIB-IV with poor performance status were treated by palliative radiotherapy in adjuvant with the Thai herbal tonic solution (Vilac Plus G716/45) daily dose 15-30 ml orally tid, pe as an additional supportive remedy.

RESULTS: Thirty cases of patients in advanced cervical cancer stage IIIB-IV with poor performance status, the median age in stage IIIB, IVA, IVB were 50 years (range 41-73 years), 50.5 years (45 years, 58 years), 69 years (67 years, 71 years) respectively. The analysis were being categorized and performed on stages IIIB, IVA, IVA with bladder cancer and IVB reporting in corresponding number of cases/total subject (percentage) were 25/30 (83.33%), 2/30 (6.67%), 1/30 (3.33%) and 2/30 (6.67%) respectively. The median tumor size for stages IIIB, [VA and IVB were 5 cm (range 2-10 cm), 5 cm (4, 6 cm) and 4 cm (2, 6 cm) respectively. The pathological identification had been classified to be squamous cell carcinomas 21/30 (70.00%), adenocarcinomas 7/30 (23.33%), small cell carcinoma 1/30 case (3.33%) and clinically staging IIIB 1/30 case (3.33%). The median time interval between teletherapy and brachytherapy was 22 days (range 7-41 days). Eventually, 84% of the stage IIIB cases were undergone by prolonged gap of more than 2 weeks of time interval between teletherapy and brachytherapy while the rest of the case (16%) received the optimal time gap of treatments. The initial complete response and partial response after 4-6 weeks of radiotherapy were 84% and 16 % respectively. The patterns of failure in stage IIIB revealed in 16 % with residual pelvic diseases (< 6 months), 4% with local pelvic recurrence (> 6 months) and 4% with distant metastases. Median follow-up period in stage IIIB was 22 months (range 2-48 months). Low radiation complications were noted, the severe radiation proctitis (grade 3) was found to be 3.33%. It was notable results in the declined BUN/Cr level in cervical cancer patients with underlying renal insufficiency/chronic renal failure patients treated by palliative radiotherapy and Thai herbal tonic solution as an additional supportive remedy had been observed in 2 cases of stage IIIB and | case of stage IVA with neither surgical intervention nor hemodialysis. CONCLUSION: Our preliminary study in the treatment of advanced cases of Ca. Cervix with palliative radiotherapy and Thai herbal medicine had shown the evidence of initial complete regression of tumour with disappearance of foul smell discharge as high as 84% with low rate of local pelvic recurrence, low distant metastases and low rate of radiation complication. However, the study has a limitation on the number of cases and a short follow up period. Moreover, this treatment modality had shown the benefit on the declination of BUN/Cr level in some cases of those locally advanced stages III B-IV in chronic renal failure caused by chronic ureteric obstruction due to lateral spreading of the cancer pressing on both ureters, without neither surgical intervention nor hemodialysis. The declined BUN/Cr levels were the consequence of the relief of pressure effect on the ureters by the decreasing of the tumour volumes. Palliative radiotherapy with Thai herbal tonic as supportive remedy was safe, cost effective, in addition to the benefit of improval of quality of life without the toxicity of herbal medicine. Therefore, this combination of palliative radiotherapy together with Thai Herbal Medicine would be the alternative option for the palliative treatment of advanced cancer cases with poor performance status or in locally advanced cancer cases. Further studies of increasing number of cases with longer follow up period including multicenters studies should be performed in order to confirm this findings with statistical significant conclusion.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Vatanasapt V, Martin N, Sriplung H, et at. Cancer in Thailand. 1988-1991.

Khonkaen: Siriphan Press,1993:68-69. Vatanasapt V, Martin N, Sriplung H, et at. Cancer incidence in Thailand. 1988- 1991. Cancer Epidemiology, Biomarkers & Prevention 1995; 4 :475-483.

Pesee M, Tangvoraphonkchai V, Boonvisuth V, et al. Radiotherapy alone in the treatment of carcinoma of the uterine cervix in Srinagarind Hospital: Analysis of treatment failure. Thai J Radiol. 1989;26(1):67-70.

Pesee M, Tangvoraphonkchai V, Reamsini T, et al. Low dose rate brachytherapy Caesium -137 afterloading in the treatment of carcinoma of uterine cervix in Srinagarind hospital: Analysis ofa actuarial survival rate. Thai J Radiol. 1995;1(3):125-30.

Tungsubutra K, Pesi M, Tangvoraphonkchai V. Problems in treatment of cancer in the rural areas and the remedies. In Mould RF, Tungsubutra K, eds. Diagnosis and treatment of carcinoma of the cervix in developing areas. Bristol and Boston: Adam Hilger 1985; 219-22.

Tungsubutra K, Tangvoraphonkchai V, Pesi M. Cancer epidemiology in Thailand. In Mould RF, Tungsubutra K, eds. Diagnosis and treatment of carcinoma of the cervix in developing areas. Bristol and Boston: Adam Hilger 1985; 187-90

Tangvoraphonkchai V, Pesee M, Boonvisuth V, et al. Tumor registry: An overview of problems shooting in radiotherapy. Thai J Radiol 1989; 26(1): 95-8.

Chao K.S.C , Perez CA, Bradym LW, eds. Uterine Cervix in Textbook of Radiation Oncology. Management Decisions. Lippincott Williams & Wilkins, Philadelphia. 2002;489- 509.

Perez CA, Breaux S, Bedwinek JM, etal. Radiation Therapy Alone in the Treatment of Carcinoma of the Uterine cervix. IT. Analysis of Complication. Cancer 1984;54:235-246.

Suntorntanasat T, Banchonglikitkul C, Klungsupaya P, et al. Acute oral toxicity test Herbal tonic solution (G7 16/45). An analytical report. Thailand Institute of Scientific and Technological Research. September 2003, 1-8.

Amadi Pirasahid P, Suntorntanasat T, Analytical report on Herbal tonic solution. (G716/ 45). Ananalytical report. Thailand Institute of Scientific and Technological Research. September 2004, 1-3.

Durand Phillippe,Prost Michel. In Vitro study of Vilac Plus analysis. Kirial International laboratories KRL Test (SPIRAL-No. Patent FR 2. 642. 526), 3 rue des Mardors 21560 COUTERNON, France.July 2006, 1-4.

Lee S-S, Wei Y-H, Chen C-F, et al. Anti -tumor effects of polysaccharides of Ganoderma lucidum. Proc Int Symposium Ganoderma Sci, Auckland, 27-29 April, 2001, 1-6

Murakami A, Jiwajinda S, Koshimizu k, et al. Screening for in vitro anti-tumor promoting activities of edible plant from Thailand. Cancer Letters 1995; 95; 139-14

Pomros P, Sriamporn S, Tangvoraphonkchai V, et al. Factors A ffectng Survival of Cervical Cancer Patients Treated at the Radiation Unit of Srinarind Hospital, Khon Kaen University, Thailand. Asian Pacific Journal of Cancer Prevention 2007; 8: 297-300

Boonvisuth V, Pesee M, Tangvophonchai V, et al. Radiotherapy alone in the treatment of carcinoma of the uterine cervix in Srinagarind Hospital: Analysis of Complication. Thai J Radiol. 1989; 26(2): 139-146.

Perez CA, Breaux S, Madoc-Jones H et al. Radiation therapy alone in the treatment of carcinoma of uterine cervix.]. Analysis of tumor recurrence. Cancer 1983; 51: 1393-1402

Kataoka M, Kawamura M, Nishiyama Y, Hamada K, Hamamoto K, Matsu-Ura S. Results of the combination of external-beam and high-dose-rate intracavitary irradiation for patients with cervical carcinoma. Gynecol Oncol 1992; 44: 48-52.

Khoo-Tan HS, Chua EJ. Radical radiotherapy for carcinoma of the uterine cervix using high dose rate brachytherapy--a preliminary report. Ann Acad Med Singapore 1996; 25: 367-70.

Arai T, NakanoT, Morita S, et al. High dose rate remote afterloading intracavitary radiation therapy for cancer of the uterine cervix. A 20 -year experience. Cancer 1992; 69:175-180.

Perez CA, Kuske RR, Camel HM, et al. Analysis of pelvic tumor control and impact on survival in carcinoma of the uterine cervix treated with radiation therapy alone. Int J Radiat Oncol Bio Phys 1988; 14: 613-621.

Perez CA, et al Uterine cervix in textbook of principles and practice of radiation oncology, third edition. Perez CA, Brady LW, eds. Lippincott-Raven publishers. New York. 1997: 1806-1808.

Kirsten F, Atkinson Kh, Coppelsen JVM, et al. Combination chemotherapy followed by surgery or radiotherapy in patients with locally advanced cervical cancer. Br. J Obstet Gynaecol 1987; 94: 583-588.

Sundfor K, Trope CG, Hogberg T, et al. Radiotherapy and neoadjuvant chemotherapy for cervical cancer. Arandomized multicenter study of sequential cisplatin and 5-fluorouracil and radiotherapy in advanced cervical carcinoma stage IIIB and IVA. Cancer 1996; 77: 2371-2378.

Symonds RP, Burnett RA, Habeshew T, et al. The prognostic value of chemotherapy given before radiotherapy in advanced cancer of cervix. Br J Cancer 1989; 59: 473-475.

Lara PC, Garcia Puche JL, Pedraza V. Cisplatin- ifosfamide as neoadjuvant chemotherapy in stage IIIB cervical uterine squamous cell carcinoma. Cancer chemother Pharmacol 1990; 26: 36-38.

Thomas GM. Is neoadjuvant chemotherapy auseful strategy for the treatment of stage IB cervix cancer [Editorial]. Gynecol Oncol 1993; 49: 153-155.

Pesee M, Kirdpon W, Puapairoj A, et al. Palliative treatment of advanced lung cancer with radiotherapy and Thai herbal medicine as supportive remedy. The Asean J of Riology 2006; 12(3): 149-176.

Pesee M, Kirdpon W, Puapairoj A, etal. Palliative treatment of advanced subependymal oligodendroglioma with radiotherapy and Thai herbal medicine as supportive remedy. The Asean J of Riology 2006; 12(3):135-148.

Takagi A, Matsuzaki T, Sato M, etal. Enhancement of natural killer cytotoxicity delayed murine carcinogenesis by a probiotic microorganism. Carcinogenesis 2001 ; 22(4): 599-605.

Takagi M. Immunomodulation by trestment with Lactobacillus casei strain shirota. IntJ Food Microbiol 1998; 41(2): 33-40.

Salminen S, Isolauri E , Salminen E. Probiotics and stabilization of the gut mucosal barrier. Asia Pacific J Clin Nutr 1996; 5(1): 53-56

Wasser SP. Review of Medicinal Mushrooms Advances: Good news from old allies. Herbalgram 2002; 56: 28-33

Kim HW, Kim BK. Biomedicinal triterpenoids of Ganoderma lucidum (Aphyllophoromycetideae). Int J of Med Mushroom 1999; 1:121 -38.

Van der Hem LG Ling Zhi-8. Studies of a new immuno modulating agent. Trasplantation. 1995; 60: 438-443.

Wang SY. Anti-tumor effect of Ganoderma Lucidum is mediated by cytokines released from activated macrophages and T-lymphocytes. Int J Cancer 1997;70:699-705.

Murakami A, KondoA , Nakamura Y, et al. Possible antitumor Promoting and identification of Active Constituent Cardomoin of Boesenbergia Pandurata. Biosci Biotech Biochem 1993; 57 (11): 1971-3.

Cherng JM, Shieh DE, Chiang W, et al. Chemopreventive effects of minor dietary constitutents in common foods on human cancer cells. Bioscience, Biotechnology and Biochemistry 2007; 71(6): 1500-1504

Morita N, Hayashi K, Fujita A, et al. 40. Extraction of antiviral substances from Houttuynia cordata Thunb. Chemical abstract 1995; 123: 93249j.

Hayashi K, Kamiya M , Hayashi T. Virucidal effects of the steam distillate from Houttuynia cordata and its components on HSV-1, influenza virus and HIV. Plant Med.1995; 61 (3): 237-41

Downloads

Published

2023-04-23

How to Cite

1.
PESEE M, KIRDPON W, KIRDPON S, PUAPAIROJ A, PRATHNADI P. PALLIATIVE TREATMENT OF ADVANCED CERVICAL CANCER WITH RADIOTHERAPY AND THAI HERBAL MEDICINE AS SUPPORTIVE REMEDY. ASEAN J Radiol [Internet]. 2023 Apr. 23 [cited 2024 Dec. 12];13(3):171-84. Available from: https://asean-journal-radiology.org/index.php/ajr/article/view/801

Issue

Section

Original Article

Most read articles by the same author(s)

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.